Tyro 3 receptor tyrosine kinase and its ligand, Gas6, stimulate the function of osteoclasts

Stem Cells

Volumn 16, Issue 3, 1998, Pages 229-238

  Nakamura, Yuka S ^a   Hakeda, Yoshiyuki ^b   Takakura, Nobuyuki ^a   Kameda, Takashi ^b   Hamaguchi, Isao ^a   Miyamoto, Takeshi ^a   Kakudo, Shinji ^c   Nakano, Toru ^c   Kumegawa, Masayoshi ^b   Suda, Toshio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

Author keywords

Bone resorption; Gas6; Osteoclasts; Tyro 3

Indexed keywords

ACID PHOSPHATASE; PROTEIN S; PROTEIN TYROSINE KINASE; VITAMIN K GROUP;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LOCALIZATION; HISTOLOGY; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; POLYMERASE CHAIN REACTION; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS; TYRO;

EID: 15644369350     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.160229     Document Type: Article

References (50)

1. Walker DG. Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants. J Exp Med 1975;142:651-653.
2. Ash P, Loutit JF, Townsend KM. Osteoclasts derived from haematopoietic stem cells. Nature 1980;283:669-670.
3. Ko JS, Bernard GW. Osteoclast formation in vitro from bone marrow mononuclear cells in osteoclast-free bone. Am J Anat 1981;161:415-425.
4. Kurihara N, Suda T, Miura Y et al. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 1989;74:1295-1302.
5. Tanaka S, Takahashi N, Udagawa N et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 1993;91:257-263.
6. Fuller K, Owens JM, Jagger CJ et al. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 1993;178:1733-1744.
7. Kurihara N, Iwama A, Tatsumi J et al. Macrophage-stimulating protein activates STK receptor tyrosine kinase on osteoclasts and facilitates bone resorption by osteoclast-like cells. Blood 1996;87:3704-3710.
8. Ohashi K, Mizuno K, Kuma K et al. Cloning of the cDNA for a novel receptor tyrosine kinase, Sky, predominantly expressed in brain. Oncogene 1994;9:699-705.
9. Mark MR, Scadden DT, Wang Z et al. rse, a novel receptor-type tyrosine kinase with homology to Axl/Ufo, is expressed at high levels in the brain. J Biol Chem 1994;269:10720-10728.
10. Fujimoto J, Yamamoto T. brt, a mouse gene encoding a novel receptor-type protein-tyrosine kinase, is preferentially expressed in the brain. Oncogene 1994;9:693-698.
11. Dai W, Pan H, Hassanain H et al. Molecular cloning of a novel receptor tyrosine kinase, tif, highly expressed in human ovary and testis. Oncogene 1994;9:975-979.
12. O'Bryan JP, Frye RA, Cogswell PC et al. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 1991;11:5016-5031.
13. Janssen JW, Schulz AS, Steenvoorden AC et al. A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene 1991;6:2113-2120.
14. Rescigno J, Mansukhani A, Basilico C. A putative receptor tyrosine kinase with unique structural topology. Oncogene 1991;6:1909-1913.
15. Graham DK, Dawson TL, Mullaney DL et al. Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ 1994;5:647-657.
16. Jia R, Hanafusa H. The proto-oncogene of v-eyk (v-ryk) is a novel receptor-type protein tyrosine kinase with extracellular Ig/GN-III domains. J Biol Chem 1994;269:1839-1844.
17. Schulz NT, Paulhiac CI, Lee L et al. Isolation and expression analysis of tyro3, a murine growth factor receptor tyrosine kinase preferentially expressed in adult brain. Mol Brain Res 1995;28:273-280.
18. Crosier PS, Lewis PM, Hall LR et al. Isolation of a receptor tyrosine kinase (DTK) from embryonic stem cells: structure, genetic mapping and analysis of expression. Growth Factors 1994;11:125-136.
19. Crosier PS, Hall LR, Vitas MR et al. Identification of a novel receptor tyrosine kinase expressed in acute myeloid leukemic blasts. Leuk Lymphoma 1995;18:443-449.
20. Neubauer A, Fiebeler A, Graham DK et al. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood 1994;84:1931-1941.
21. Varnum BC, Young C, Elliott G et al. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth arrest-specific gene 6. Nature 1995;373:623-626.
22. Stitt TN, Conn G, Gore M et al.The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 1995;80:661-670.
23. Manfioletti G, Brancolini C, Avanzi G et al. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993;13:4976-4985.
24. Tezuka K, Sato T, Kamioka H et al. Identification of osteopontin in isolated rabbit osteoclasts. Biochem Biophys Res Commun 1992;186:911-917.
25. Iwama A, Okano K, Sudo T et al. Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 1994;83:3160-3169.
26. Takakura N, Yoshida H, Kunisada T et al. Involvement of platelet-derived growth factor receptor-alpha in hair canal formation. J Invest Dermatol 1996;107:770-777.
27. Kakudo S, Miyazawa K, Kameda T et al. Isolation of highly enriched rabbit osteoclasts from collagen gels: a new assay system for bone-resorbing activity of mature osteoclasts. J Bone Miner Metab 1996;14:129-136.
28. Tondravi MM, McKercher SR, Anderson K et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 1997;385:81-84.
29. Wang ZQ, Ovitt C, Grigoriadis AE et al. Bone and haematopoietic defects in mice lacking c-fos. Nature 1992;360:741-745.
30. Grigoriadis AE, Wang ZQ, Cecchini MG et al. c-fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994;266:443-448.
31. Yoshida H, Hayashi S, Kunisada T et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442-444.
32. Kodama H, Yamasaki A, Nose M et al. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 1991;173:269-272.
33. Sly WS, Hewett-Emmett D, Whyte MP. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 1983;80:2752-2756.
34. Yamamoto T, Kurihara N, Yamaoka K et al. Bone marrow-derived osteoclast-like cells from a patient with craniometaphyseal dysplasia lack expression of osteoclast-reactive vacuolar proton pump. J Clin Invest 1993;91:362-367.
35. Soriano P, Montgomery C, Geske R et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.
36. Tanaka S, Takahashi N, Udagawa N et al. Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption. J Cell Biochem 1995;58:424-435.
37. Tanaka S, Amling M, Neff L et al. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 1996;83:528-531.
38. Polte TR, Hanks SK. Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130(Cas)) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs. J Biol Chem 1997;272:5501-5509.
39. Insogna KL, Sahni M, Grey AB et al. Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest 1997;100:2476-2485.
40. Hakeda Y, Kumegawa M. The growth and culture of bone cells: osteoclastic. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego: Academic Press, Inc. 1996:1217-1220.
41. Goruppi S, Ruaro E, Schneider C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 1996;12:471-480.
42. Nakano T, Kawamoto K, Higashino K et al. Prevention of growth arrest-induced cell death of vascular smooth muscle cells by a product of growth arrest-specific gene, gas6. FEBS Lett 1996;387:78-80.
43. Li R, Chen J, Hammonds G et al. Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci 1996;16:2012-2019.
44. Crosier PS, Freeman SA, Orlic D et al. The Dtk receptor tyrosine kinase, which binds protein S, is expressed during hematopoiesis. Exp Hematol 1996;24:318-323.
45. Godowski PJ, Mark MR, Chen J et al. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 1995;82:355-358.
46. Maillard C, Berruyer M, Serre CM et al. Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology 1992;130:1599-1604.
47. Pan EY, Gomperts ED, Millen R et al. Bone mineral density and its association with inherited protein S deficiency. Thromb Res 1990;58:221-225.
48. Ohashi K, Nagata K, Toshima J et al. Stimulation of sky receptor tyrosine kinase by the product of growth arrest-specific gene 6. J Biol Chem 1995;70:22681-22684.
49. Sato T, Hakeda Y, Yamaguchi Y et al. Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/PA6). J Cell Physiol 1995;164:197-204.
50. Fuller K, Owens J, Chambers TJ. The effect of hepatocyte growth factor on the behaviour of osteoclasts. Biochem Biophys Res Commun 1995;212:334-340.